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Abstract 
Background: Chronic fatigue (CF) reflects an imbalance of inter-organ functions or of the four essential physiological 
components qi, blood (xue), yin, and yang. CF can be subdivided into different patterns. However, there are no diag-
nostic methods for CF. This study aimed to clinically validate a pattern identification method by identifying correla-
tions between CF and responses to the qi blood yin yang deficiency questionnaire (QBYY-Q).
Methods: Participants were recruited between May and June 2014 through the Kyung Hee University Korean 
Medicine hospital website and via posters and comprised 129 CF patients diagnosed with the United States Cent-
ers for Disease Control and Prevention (1994) criteria. Participants who had organic diseases that explained the CF 
were excluded. A total of 159 participants were asked to complete the QBYY-Q, the fatigue severity scale, and the 
Chalder fatigue scale. The latter two questionnaires were used to assess convergent validity with the QBYY-Q. Among 
the 129 CF participants, 70 and 59 had chronic fatigue syndrome and idiopathic chronic fatigue, respectively. Two 
Korean medical doctors independently assessed participants’ qi, blood, yin, and yang deficiency patterns using QBYY 
deficiency pattern identification guidelines. Based on the results of a preliminary study of the QBYY-Q, we selected 32 
reliable items for symptoms corresponding to each deficiency pattern. The items were used to estimate internal con-
sistency and construct validity. Multinomial logistic regression analysis was performed for scores on each deficiency 
pattern.
Results: The data were means and standard deviations or numbers of participants and proportions for continuous 
and categorical variables, respectively. A statistical significance level of P < 0.05 was assumed. The QBYY-Q showed 
satisfactory internal consistency. Explanatory factor analysis extracted two factors for each deficiency pattern. The 
percentages of explained variance for qi, blood, yin, and yang deficiency were 45.1, 58.0, 52.2, and 63.4 %, respectively. 
Each QBYY-Q deficiency score was positively associated with each corresponding deficiency pattern. Qi deficiency was 
used as a reference category. Odds ratios of blood, yin, and yang deficiency were 10.97, 10.69, and 14.64, respectively.
Conclusion: The QBYY-Q was suitable for estimating the influences of qi, blood, yin, and yang deficiencies in CF.
Trial registration This trial was registered with the Korean Clinical Trial Register (KCT0001199)
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Background
Fatigue is a state of subjective tiredness and can be sub-
divided into prolonged fatigue and chronic fatigue (CF). 
CF is a condition of subjective tiredness and is reported 
by nearly 10  % of the global population [1]; it can be 
categorized as either explained CF or unexplained CF. 
Unexplained CF is further subdivided into chronic 
fatigue syndrome (CFS) and idiopathic chronic fatigue 
(ICF) [2]. CFS is characterized by severe disabling fatigue 
and a combination of four additional symptoms that 
may include impairments in cognitive or neurological 
function, sleep dysfunction, musculoskeletal pain, and 
endocrine or immune dysfunction (Table  1). Addition-
ally, alternative medical and psychiatric causes must have 
been excluded, and the condition must have persisted 
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for at least 6 months. ICF meets all the criteria for CFS 
except for the four additional symptoms.
Studies of CFS and ICF indicate prevalence rates of 
approximately 10 and 1  % of the general population, 
respectively [3]. The estimated prevalence of CF in the 
Republic of Korea is between 0.6 and 2 % of the general 
adult population [4]. Several hypotheses have been pro-
posed for the pathogenesis of CF, including oxidative 
stress, hypothalamic–pituitary–adrenal axis abnormali-
ties, and immune dysfunction [5–7]. Western medicine 
offers no objective diagnostic methods or effective thera-
pies for CF and the recommended drugs have many side 
effects [8–11]. CFS and ICF patients tend to be interested 
in complementary and alternative medicine treatments 
[9, 12, 13].
An individual’s constitution and current health status 
can be conceptualized in terms of the balance between 
the qi and blood (xue) conditions of the internal organ 
functions and of the co-existing yin and yang (which con-
stitute the physical form and functioning of the human 
body and its deficient and excessive energetic qualities) 
[9, 14, 15]. Treatments such as acupuncture, moxibustion, 
herbal medicine, and qigong restore the balance of the 
four essential components of the human body: qi, blood, 
yin, and yang.
Unexplained CF can be classified as either a deficiency 
syndrome or an excess syndrome; these syndromes refer 
to the deficiency or excess of qi, blood, yin, and yang [16, 
17]. Unexplained CF is usually considered a deficiency 
pattern representing an imbalance of the four essen-
tial components; most cases are treated by invigorating 
qi and yang and nourishing blood and yin [9, 18, 19]. CF 
treatments are based on individual patterns of body con-
stitution or pattern identification (PI); most patients are 
diagnosed according to four patterns of body constitution 
that involve the five major organs: the heart, liver, spleen, 
lungs, and kidney. These patterns are qi deficiency (QD, 
i.e., decreases in visceral functions and body resistance), 
blood deficiency (BD, i.e., failure to nourish the organs, 
tissues, and meridians), yin deficiency and yang deficiency 
(YnD and YgD, i.e., failure to maintain normal function of 
internal organs) [9, 11, 18].
This study aimed to clinically validate a PI diagnos-
tic method by testing for correlations between CF and 




The study protocol was reviewed and approved by the 
Institutional Review Board of the Cheonan Oriental Hos-
pital at Daejeon University (authorization number: 2014-
A01-02) and was registered with the clinical research 
information service (registration number: KCT0001199) 
(Additional file 1).
Study design
This study was designed as a single-center, cross-sec-
tional, case-controlled study, and it was performed at 
the Cheonan Oriental Hospital of Daejeon University in 
Cheonan, South Korea from May to June 2014. The pro-
cedures of this study were depicted in Fig. 1.
Participants
Participants were recruited by advertising on hospi-
tal websites and posters displayed in hospitals and local 
universities, Seoul, Republic of Korea from May to June 
2014. They went through telephone pre-screening by the 
clinical study coordinator to ensure that CF patients met 
the inclusion criteria of “males and females aged 19–39’’ 
and “the presence of CF that is continuous and repeti-
tive for more than 6  months”. Then, participants visited 
the clinical study center and go through a more in-depth 
screening process to determine whether they satisfied the 
inclusion criteria.
Participants who worked at night or drank alcohol 
more than twice per week were excluded. We excluded 
the participants who had organic diseases for explained 
CF, such as acute or chronic liver disease (e.g., hepatitis, 
and liver cirrhosis); anemia; tuberculosis; chronic lung 
Table 1 Diagnosis CDC-1994 criteria
Chronic fatigue syndrome symptoms
A. Major criteria (both criteria required)
 1. Severe fatigue >6 months
  a. Persistent or relapsing in course
  b. Does not resolve with bed rest
  c. Significant reduction in average daily activity (below 50 % of prior 
activity)
 2. Other causes excluded
  a. See fatigue causes
B. Minor criteria (4 or more present for 6 months)
 1. Headache
  a. New type, severity or pattern
  b. Typically non-focal headache
 2. Migratory polyarthralgias
  a. Non-inflammatory (no swelling or erythema)
 3. Myalgias
 4. Postexertional malaise or fatigue
  a. Duration >24 h
 5. Short-term memory or concentration impaired
 6. Pharyngitis
 7. Tender cervical or axillary adenopathy
 8. Non-restorative sleep
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disease; cardiovascular disease (e.g., heart failure, hyper-
tension); endocrine/metabolic disease (e.g., diabetes, 
thyroid gland disease, and severe obesity); autoimmune 
disease (e.g., rheumatoid arthritis, systemic lupus erythe-
matosus, and multiple sclerosis); malignant tumors; or 
infectious disease were excluded. In addition, CF patients 
with psycho-social diseases, such as depression, anxiety 
neurosis, recent severe stress, schizophrenia, alcoholism, 
or an eating disorder (e.g., anorexia nervosa, bulimia ner-
vosa), were excluded [12, 13]. Cut-offs of BMI (≥30 kg/
m2) have shown good specificity in diagnosing severe 
obesity, which is defined as BMI  ≥30  kg/m2 based on 
measured weight and height and is a type of metabolic 
disease [20, 21]. The participants were informed of the 
entire process of the clinical study and were asked to sign 
informed consent forms (Additional file 2).
The final participants included 129 patients with unex-
plained CF and 30 controls. The enrolled patients mainly 
suffered from fatigue lasting more than 6  months. The 
CDC-1994 criteria for CFS [22] were used to distinguish 
between CFS and ICF, using the cutoff of 4 among the 8 
symptoms in the minor criteria, respectively (Table  1). 
CFS patients complained of major criteria symptoms and 
more than four of the minor criteria symptoms, and ICF 
patients complained of major criteria symptoms and less 
than four of the minor criteria symptoms. If a subject 
complained of fatigue lasting more than 6 months, head-
ache and pharyngitis, the subject was diagnosed as ICF. 
Among the attending 129 CF patients, 70 and 59 were 
found to have CFS and ICF, respectively.
The control (30 healthy participants) came to the 
same clinic who worked at night and drank alcohol were 
excluded. The control group consisted of participants 
who satisfied the following criteria: (1) not meeting the 
CFS and ICF criteria from CDC-1994; (2) absence of 
organopathy; and (3) normal results of laboratory tests 
and radiological examinations.
Of the 159 participants, two participants were excluded 
due to noncompliance with the process described in the pro-
tocol; therefore, 157 participants were included in this study.
Fig. 1 Flow diagram of the procedures of the clinical study
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Pattern diagnosis
There is no “gold standard” for pattern diagnosis. Our 
previous study demonstrated discrepancies in the diag-
noses of QD, BD, YnD, and YgD among Korean medical 
doctors (KMDs) [23]. To increase the internal consist-
ency of KMD expert pattern diagnosis, we created PI 
guidelines for QD, BD, YnD, and YgD with PI experts, 
using data from previous studies [9, 24] and the stand-
ard Korean medical literature [22] 4  months before the 
study commenced. The developed PI guidelines were 
validated after consultation with experts. Based on the PI 
guidelines, two KMDs with 4 years of clinical experience 
independently diagnosed the participants’ deficiency sta-
tus; the KMDs were blinded to the results of the diagno-
ses. Participants for whom the KMD diagnoses disagreed 
were excluded from the analysis.
Measurements
QBYY‑Q scales
In our previous studies, items related to QD, YnD, YgD, 
and BD were systematically reviewed [9, 25–27], and a 
QBYY-Q constructed by a panel of experts was selected 
for use in a pilot study. This QBYY-Q had been estab-
lished by an expert panel of 27 KMDs in a previous 
study [28]. A pilot study was performed to determine 
the reliability and validity of the QBYY-Q for 100 partici-
pants with CF [23]. After these participants completed 
the QBYY-Q, the KMDs divided the patients into four 
groups: QD, BD, YnD, and YgD. After 3  weeks, the 100 
participants were retested in the same way. The results 
from our pilot study showed that Cronbach’s α coefficient 
was 0.916 for internal consistency of the QBYY-Q. Con-
struct validity analyzed using exploratory factor analy-
sis (EFA) produced four factors with eigenvalues greater 
than 1.0. Factors 1, 2, 3, and 4 were identified as QD, YnD, 
YgD, and BD, respectively. However, four items, “men-
strual cycle slowdown,” “decreased masculine energy,” 
“damp and cold penis,” and “decreased sexual desire,” pro-
duced an item-total correlation of less than 0.5. Because 
the results indicated that the four items were not equiv-
alent to the others, these items were excluded from the 
validity tests. Test–retest reliability was high (intraclass 
correlation coefficient  =  0.699) [23]. Consequently, the 
final version of the QBYY-Q included 32 sign and symp-
tom entries consisting of nine QD, eight BD, nine YnD, 
and six YgD pattern items. The order of the 32 QBYY-Q 
pattern items was reversed to reduce bias (Additional 
file  3). The QD pattern included two signs, enervation 
and shortage of qi or faint breathing, and the BD pattern 
included three signs, pale complexion, sweating dur-
ing the day, and palpitations (a subjective sensation of 
rapid and forceful beating of the heart). The YnD pattern 
was divided into following two signs: (1) dry skin and 
mouth; and (2) heat vexation and fever accompanied by 
uneasiness or restlessness. The YgD pattern was divided 
into two signs, cold in the extremities up to the knees 
and elbows and diarrhea. The severity of each item was 
graded using the following 4-point scale: 1  =  strongly 
disagree, 2 = disagree, 3 = agree, and 4 = strongly agree. 
The scores for each item were totaled, and QD-Q, BD-Q, 
YnD-Q, and YgD-Q scores calculated.
Fatigue severity scale (FSS)
The FSS is a self-rating questionnaire comprising nine 
items that are scored between 1 (completely disagree) 
and 7 (completely agree). The items assess the extent of 
fatigue symptoms and their impact on patient function-
ing (including motivation; exercise; physical functioning; 
ability to perform duties; and interference with work, 
family, or social life) [29]. Example items on the question-
naire are “exercise brings on my fatigue” and “my fatigue 
is very debilitating”; higher item scores indicate a greater 
degree of fatigue.
Chalder fatigue scale–Korean version (CFS‑K)
The CFS is a self-reported questionnaire that measures 
fatigue intensity on a 4-point scale (0 = less than usual to 
3 = much more than usual) [30]. Symptoms assessed by 
the scale are divided into two subcategories: seven items 
related to physical symptoms, and four items related to 
mental fatigue. Although the internal consistency of the 
CFS-K has not been fully reported, many studies using 
versions of the CFS in different languages have shown 
strong internal consistency for both the physical and 
mental symptoms of fatigue. Likert scoring with weights 
was used to score the magnitude of fatigue [30].
Statistical analysis
The data were represented as means ±  standard devia-
tions (SDs) or as numbers of participants and proportions 
for continuous and categorical variables, respectively. All 
statistical analyses were performed using R software (The 
R Foundation), version 3.1.1, on a Windows 7 platform. 
R software is a free software environment for statistical 
computing and graphics [31]. The level of significance 
was set at P < 0.05 for all analyses. Inter-rater agreement 
for the two KMDs’ diagnoses of QD, BD, YnD, and YgD 
was evaluated using Cohen’s κ coefficient. Differences 
between CF patients (CFS and ICF) and the non-CF 
group were tested using a one-way ANOVA for continu-
ous variables and Pearson’s Chi square test for categori-
cal variables. The Keiser–Meyer–Olkin (KMO) test was 
used to test sample adequacy (considered acceptable 
if the KMO constant is >0.60) [32]. The KMO was used 
to check the matrix of correlations for the applicability 
of factorial analysis, and then a principal axis factoring 
Page 5 of 11Kim et al. Chin Med  (2016) 11:24 
extraction method was applied. Construct validity for 
each deficiency scale on the questionnaire was esti-
mated by performing EFA with a combination of mini-
mum residual extraction and promax rotation. For each 
deficiency scale, conceptual factors were identified by 
examining the factor loadings. The internal consistency 
of each deficiency scale was also tested using Cronbach’s 
α coefficient. Convergent validity of deficiency scores 
derived from the four QBYY-Q scales and the total scores 
on the CFS-K and FSS was assessed using Spearman’s 
correlation coefficient. The mean differences in deficiency 
scores between the CF and non-CF groups were exam-
ined using a one-way ANOVA test. In addition, binary 
logistic regression analysis was used to estimate the odds 
ratios (ORs) of CF (CFS + ICF versus no CF) in the KMD 
diagnoses of QD, BD, YnD, and YgD to confirm the asso-
ciations between CF and PI. Both CF and PI could have 
been influenced by other confounding factors; therefore, 
age and sex were included to estimate the adjusted ORs 
for CF. Discriminative validity was determined using the 
ORs of the four deficiency scale scores derived from a 
multinomial logistic regression model.
Results
Demographic characteristics
Because of the absence of a gold standard for pattern 
diagnosis, six of the 157 participants showed discrepan-
cies in pattern diagnoses and were excluded to increase 
the internal consistency. Therefore, 151 participants were 
included in the analysis. Table 2 shows the demographic 
characteristics of the 65 participants with CFS, the 56 
participants with ICF, and the 30 control subjects in the 
non-CF group. For most of the characteristics, there were 
no significant differences among the CF groups (CFS and 
ICF) and the control group. However, the age and sex dis-
tributions showed significant differences among the three 
groups. The means and SDs for age were 29.7 ± 4.9 years 
for participants with CFS, 27.4  ±  5.2  years for partici-
pants with ICF, and 26.0 ± 3.7 years for the control group 
(F = 7.09, P = 0.001). The proportions of women in the 
CFS, ICF, and control groups were 64.6, 35.7, and 50.0 %, 
respectively (χ2 = 10.07, P = 0.007).
KMD inter‑rater agreement
Cohen’s κ coefficient was 0.95 (Z  =  20.69, P  <  0.001), 
which indicated that the agreement between the two 
KMDs was sufficiently strong. The two KMDs differed in 
their PI diagnoses for six (3.8 %) of the 157 participants 
(Table 3).
Internal consistency and construct validity of the QBYY‑Q
The internal consistency and construct validity of each of 
the QBYY-Q scales were assessed by merging the current 
study and pilot study data (totaling 252 cases). The Cron-
bach’s α coefficients of the nine QD items (QD-Q), the 
eight BD items (BD-Q), the nine YnD items (YnD-Q), and 
the six YgD items (YgD-Q) were 0.816, 0.826, 0.807, and 
0.717, respectively.
KMO tests of sphericity confirmed that each QBYY-
Q scale contained an eligible number of items and a 
sufficient sample size (QD-Q  =  0.856, BD-Q  =  0.833, 
YnD-Q  =  0.807, YgD-Q  =  0.702). Two factors were 
extracted for each QBYY-Q scale following EFA with 
Table 2 Demographic characteristics of  participants 
with CF (CFS and ICF) and controls
The data are represented as the means ± SDs or as numbers of participants and 
proportions; N (%) for continuous and categorical variables, respectively. One-
way ANOVA was performed for continuous variables and Pearson’s χ2  test for 
categorical variables
CFS chronic fatigue syndrome, ICF idiopathic chronic fatigue, SBP systolic blood 
pressure, DBP diastolic blood pressure, QD qi deficiency, BD blood deficiency, YnD 
yin deficiency, YgD yang deficiency
Chronic fatigue Controls 
(n = 30)
P value
CFS (n = 6 5) ICF (n = 56)
Age (years) 29.7 ± 4.9 27.4 ± 5.2 26.0 ± 3.7 0.001
Sex (female) 42 (64.6) 20 (35.7) 15 (50.0) 0.007
BMI (kg/m2) 22.8 ± 3.5 22.3 ± 3.0 21.8 ± 3.1 0.746
SBP (mm Hg) 116.3 ± 11.0 116.8 ± 10.2 119.2 ± 12.7 0.471
DBP (mm Hg) 69.5 ± 11.1 71.8 ± 9.0 71.2 ± 12.5 0.471
Pulse rate  
(beats/min)
71.4 ± 8.9 70.0 ± 6.3 72.0 ± 9.5 0.482
Body tempera-
ture (°C)
36.4 ± 0.2 36.4 ± 0.2 36.4 ± 0.2 0.601
Smoking 18 (27.7) 13 (23.2) 4 (13.3) 0.305
Regular  
exercise
20 (30.8) 27 (48.2) 12 (40) 0.145
Regular diet 36 (55.4) 33 (58.9) 19 (63.3) 0.76
Pattern identification
 QD 16 (24.6) 13 (23.2) 14 (46.7) 0.129
 BD 13 (20) 18 (32.1) 6 (20)
 YnD 16 (24.6) 14 (25) 6 (20)
 YgD 20 (30.8) 11 (19.6) 4 (13.3)
Table 3 Agreement results in the KMD diagnoses (n = 157)
KMD Korean medical doctor, QD qi deficiency, BD blood deficiency, YnD yin 
deficiency, YgD yang deficiency
KMD diagnoses KMD #1
QD BD YnD YgD
KMD #2 QD 43 0 0 1
BD 1 37 1 0
YnD 1 2 36 0
YgD 0 0 0 35
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minimum residual extraction and promax rotation. 
The EFA results for each QBYY-Q scale are shown in 
Table 4.
Convergent validity of the QBYY‑Q
The convergent validity of each QBYY-Q scale was 
assessed with the FSS and CFS-K using pairwise Spear-
man’s correlation coefficients (Table  5). Total deficiency 
scores for the QD-Q, BD-Q, YnD-Q, and YgD-Q were cal-
culated by averaging all the items corresponding to each 
deficiency scale. Subscores for each deficiency scale were 
also obtained by averaging the items relevant to each fac-
tor, which were identified from the EFA. The QD-Q score 
correlated significantly with both the FSS (r  =  0.721, 
P  <  0.001) and the CFS-K (r  =  0.645, P  <  0.001). The 
BD-Q score also correlated significantly with the FSS 
Table 4 Extracted factor loadings of items for each QBYY-Q and the variance explained by two factors
The italic letters represents the largest loading between two factors
PI pattern identification, QD qi deficiency, QD-Q qi deficiency questionnaire, BD blood deficiency, BD-Q blood deficiency questionnaire, YnD yin deficiency, YnD-Q yin 
deficiency questionnaire, YgD yang deficiency, YgD-Q yang deficiency questionnaire, FL factor loading
PI Item Sub‑scale QD‑Q BD‑Q YnD‑Q YgD‑Q
FL1 FL2 FL1 FL2 FL1 FL2 FL1 FL2
QD QD-Q 01 Fatigue 0.821 −0.054
QD-Q 02 0.798 −0.087
QD-Q 05 0.824 −0.033
QD-Q 06 0.444 0.043
QD-Q 07 0.367 −0.107
QD-Q 09 0.287 0.160
QD-Q 03 Weakened voice −0.147 1.098
QD-Q 04 0.231 0.330
QD-Q 08 0.171 0.433
% of variance explained 27.90 17.20
BD BD-Q 01 Heart pounding 0.831 −0.081
BD-Q 02 0.865 −0.182
BD-Q 03 0.537 0.098
BD-Q 08 0.537 0.016
BD-Q 04 Pale and dry body 0.112 0.499
BD-Q 05 0.090 0.617
BD-Q 06 −0.222 0.977
BD-Q 07 0.308 0.313
% of variance explained 45.30 12.70
YnD YnD-Q 02 Rough and dry body 0.508 0.145
YnD-Q 05 0.712 −0.120
YnD-Q 06 0.770 −0.102
YnD-Q 07 0.689 −0.033
YnD-Q 01 Body steaming 0.243 0.267
YnD-Q 03 −0.042 0.741
YnD-Q 04 0.216 0.448
YnD-Q 08 −0.154 0.848
YnD-Q 09 0.054 0.388
% of variance explained 39.60 12.60
YgD YgD-Q 01 Preference for warm things 0.821 −0.120
YgD-Q 02 0.560 0.012
YgD-Q 03 0.692 −0.072
YgD-Q 04 0.417 0.225
YgD-Q 05 Diarrhea −0.146 0.939
YgD-Q 06 0.052 0.646
% of variance explained 41.50 21.90
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(r = 0.44, P < 0.001) and the CFS-K (r = 0.47, P < 0.001). 
The YnD-Q score correlated significantly with the FSS 
(r = 0.41, P < 0.001) and the CFS-K (r = 0.48, P < 0.001). 
The YgD-Q score also correlated significantly with 
the FSS (r =  0.40, P  <  0.001) and the CFS-K (r =  0.29, 
P < 0.001). Most of the subscales for the deficiency scales 
were significantly correlated with both the CFS-K and the 
FSS, with correlations ranging from 0.295 to 0.704. How-
ever, YgD-S2 was not significantly correlated with either 
the CFS-K (r = 0.083, P = 0.314) or the FSS (r = 0.152, 
P = 0.063).
Least square means of QBYY‑Q scores with CF status
The least square means of each QBYY-Q scale score 
with CF status were acquired after multivariate adjust-
ment for sex and age. Each marginal mean correspond-
ing to a QBYY-Q score was estimated from the linear 
mixed model. The least square means of each QBYY-Q 
scale for the CF and the control groups are shown in 
Fig.  2a. The total scores for the QD-Q, BD-Q, YnD-Q, 
and YgD-Q for the CFS patients were 1.962, 2.038, 1.928, 
and 1.767, respectively, and those for the control group 
were 1.615, 1.554, 1.530, and 1.411, respectively. Patients 
with a diagnosis of CFS showed significantly higher QD, 
BD, and YnD, and YgD scores than those diagnosed with 
ICF (QD-Q score: P  <  0.001; BD-Q score: P  =  0.001, 
YnD-Q score: P  =  0.002; YgD-Q score: P  =  0.024) or 
those in the control group (QD-Q score: P  =  0.042; 
BD-Q score: P = 0.001; YnD-Q score: P = 0.002; YgD-Q 
score: P  =  0.008). The profiles of the mean QBYY-Q 
scores among the control, ICF, and CFS groups are 
shown in Fig. 2b. The mean difference between the QD 
score and YgD score was significant for both the control 
(P = 0.042) and the CFS group (P = 0.001). There were 
no significant differences among QBYY-Q scores for the 
ICF group.
Association between PI and CF
To analyze the association between the KMD diagnosis 
and CF, the ICF and CFS groups were merged into one 
Table 5 Pairwise Spearman’s correlation coefficients 
of QBYY-Q scores and sub-scales of the QD-Q, BD-Q, YnD-Q 
and YgD-Q with the CFS-K and FSS
CFS-K Korean version of the Chalder fatigue scale, FSS fatigue severity scale, QD-
score qi deficiency score, BD-score blood deficiency score, YnD-score yin deficiency 
score, YgD-score yang deficiency score
CFS‑K P value FSS P value
QD-Q score 0.645 <0.001 0.721 <0.001
 QD-Q S1: Fatigue 0.653 <0.001 0.704 <0.001
 QD-Q S2: Weakened voice 0.419 <0.001 0.484 <0.001
BD-score 0.467 <0.001 0.441 <0.001
 BD-Q S1: Heart pounding 0.298 <0.001 0.366 <0.001
 BD-Q S2: Pale and dry body 0.481 <0.001 0.411 <0.001
YnD-score 0.485 <0.001 0.408 <0.001
 YnD-Q S1: Rough and dry body 0.387 <0.001 0.252 0.0018
 YnD-Q S2: Body steaming 0.411 <0.001 0.433 <0.001
YgD-score 0.291 <0.001 0.403 <0.001
 YgD-Q S1: Preference for warm  
things
0.295 <0.001 0.384 <0.001
 YgD-Q S2: Diarrhea 0.083 0.314 0.152 0.063
a b
Fig. 2 Least mean square plot for QBYY-Q scores. a Least mean squares of each QBYY-Q score according to the control, ICF, and CFS groups; b 
Least mean squares of QBYY-Q scores among the control, ICF, and CFS groups after adjustment for sex and age. Dotted lines denote the significant 
pairwise comparisons in which the P value was less than 0.05. Alphabetic notations (i.e., a, ab and b) above the standard error bars indicate the 
homogeneous groups resulting from Tukey’s HSD test for multiple comparisons
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large CF group. Table  6 shows the crude and adjusted 
ORs for the association between the KMD PI diagnoses 
and CF, which were acquired through binomial logistic 
regression. The crude ORs for BD, YnD, and YgD were 
significantly higher than the OR for QD (2.49-, 2.41-, 
and 3.74-fold, respectively). The prevalence ORs of BD, 
YnD, and YgD in model 1 were 3.41-, 3.41-, and 4.68-fold 
higher, respectively, than the OR of QD. These results 
were statistically significant (P < 0.05).
Associations between PI and CFS and QBYY‑Q scores
A multinomial logistic regression was used to examine 
associations between PI and QBYY-Q scores. The result-
ing values were ORs (95  % confidence intervals) with 
mean increments and are shown in Table  7. Using QD 
as a reference category for all PI scores, the BD, YnD, 
and YgD scale scores were positively associated with 
each corresponding deficiency pattern (adjusted ORs: 
BD-Q score  =  5.877, YnD-Q score  =  12.570, YgD-Q 
score = 13.558).
Discussion
In this study, we aimed to clinically develop a PI ques-
tionnaire and to analyze the effectiveness of the four 
QBYY-Q scales as diagnostic tools for CF subtypes. We 
examined the correlations between CF and the QBYY-
Q scales using KMD inter-rater agreement, the inter-
nal consistency and construct validity of the QBYY-Q, 
demographic characteristics, the convergent validity of 
the QBYY-Q, the least square means of the QBYY-Q 
scores with CF status, the associations between PIs and 
CF, and associations between PI and CF and QBYY-Q 
scores.
We compared the sociodemographic and clinical char-
acteristics of CF patients with those of healthy subjects; 
however, it was difficult to delineate the clinical charac-
teristics of CF in our study because of the small number 
of participants, i.e., 121 patients and 30 healthy subjects. 
In contrast to previous studies, the current study found 
no sex differences among groups, but it showed signifi-
cant differences among groups for marital status and sex 
[33, 34].
Validation of the QBYY-Q and the Delphi methods 
were conducted using two different groups of clinicians, 
which strengthened the discriminant ability of the QBYY-
Q [23, 28]. The revised QBYY-Q exhibited satisfactory 
internal consistency, with a Cronbach’s α of 0.900 for the 
overall signs and symptoms, and the internal consistency 
of each pattern was satisfactory (0.717–0.826). The strong 
internal consistency reliability for each pattern suggested 
that the pattern constructs were homogenous or that the 
signs and symptoms were appropriate measures of these 
deficiency syndrome constructs.
Table 6 Crude and adjusted odds ratios of CF by PI
Odds ratio OR (95 % confidence interval), qi deficiency was used as a reference 
category, Model 1 adjusted for sex and age, QD qi deficiency, BD blood deficiency, 
YnD yin deficiency, YgD yang deficiency, PI pattern identification
* <0.05, ** <0.01, *** <0.001
PI Crude Model 1
QD Reference Reference
BD 2.49 (0.88, 7.85) 3.41 (1.10, 11.87)*
YnD 2.41 (0.85, 7.61) 3.41 (1.13, 11.48)*
YgD 3.74 (1.19, 14.40)* 4.68 (1.35, 19.65)*
Table 7 Associations between PI and QBYY-Q scores
Odds ratio OR (95 % confidence interval) obtained from multinomial logistic regression, qi deficiency was used as a reference category, Model 1 adjusted for sex and 
age, QD qi deficiency, QD-Q qi deficiency questionnaire, BD blood deficiency, BD-Q blood deficiency questionnaire, YnD yin deficiency, YnD-Q yin deficiency questionnaire, 
YgD yang deficiency, YgD-Q yang deficiency questionnaire, FL factor loading
* <0.05, ** <0.01, *** <0.001
QD BD YnD YgD
Crude QD-Q score Reference 0.05 (0.01, 0.26) *** 0.17 (0.02, 0.61) ** 0.07 (0.01, 0.44) *
BD-Q score Reference 10.97 (2.10, 57.19) ** 1.25 (0.25, 6.32) 4.99 (0.90, 27.60)
YnD-Q score Reference 1.32 (0.21, 8.18) 10.69 (1.72, 66.42) * 0.66 (0.10, 4.51)
YgD-Q score Reference 0.64 (0.17, 2.32) 0.28 (0.07, 1.13) 14.64 (3.80, 56.38) ***
Model 1 QD-Q score Reference 0.04 (0.01, 0.24) *** 0.12 (0.02, 0.66) * 0.05 (0.01, 0.40) **
BD-Q score Reference 5.88 (1.04, 33.12) 1.07 (0.20, 5.79) 2.39 (0.38, 14.18)
YnD-Q score Reference 2.12 (0.32, 14.19) 12.57 (1.90, 83.07)** 1.22 (0.16, 9.20)
YgD-Q score Reference 0.53 (0.14, 2.01) 0.27 (0.07, 1.10) 13.56 (3.40, 53.99) ***
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The two QD factors were identified as weakness and 
shortage of qi or faint breathing. The two BD factors 
were identified as pale complexion and palpitations, i.e., 
a subjective sensation of rapid and forceful beating of the 
heart. Yin and yang deficiencies were divided into two 
factors each, as follows: (1) dry skin and mouth and heat 
vexation fever accompanied by uneasiness or restless-
ness for YnD and (2) and cold in the extremities up to the 
knees and elbows or beyond and diarrhea for YgD [35]. 
In summary, the QD, BD, YnD, and YgD scores might be 
beneficial for clarifying the characteristics of deficiency 
syndromes in clinical cases.
Convergent validity was assessed by investigating the 
relationships between the QBYY-Q scales and the CFS-K 
and FSS fatigue questionnaires. The convergent validity 
test showed that the QBYY-Q scales were significantly 
correlated with CFS-K and FSS scores (0.29 < r < 0.72).
Additionally, our study explored biochemical dif-
ferences in the blood between the CF and control 
groups. The blood biochemistry and complete blood 
cell counts fell within the normal laboratory ranges [14, 
35–37]. However, a CF diagnosis with YgD was signifi-
cantly correlated with hemoglobin (r = −0.28) and red 
blood cell counts (r = −0.29), and a CF diagnosis with 
YnD was significantly correlated with chloride levels 
(r = 0.28). Statistically negative correlation coefficients 
of hematocrit (r  =  −0.37), hemoglobin (r  =  −0.35), 
red blood cells (r  =  −0.32), aspartate transaminase 
(r = −0.29), and alanine transaminase (r = −0.28) were 
observed in CF patients with BD. These data suggest 
that CF patients showed differences in physiological 
homeostasis.
YgD of the spleen and kidney is characterized by cold 
limbs, listlessness, cold and pain in the waist and knee 
joints, a pale tongue with a white coating, and a deep 
and thready pulse [9]. The cross-tabulation results of CF 
and the PIs showed that the YgD OR (4.68, CI 1.347–
19.65) was significantly higher than the ORs of the other 
patterns (Table  6). The use of a questionnaire for defi-
ciency syndromes might help to identify appropriate 
qi, blood, yin, and yang nourishing treatments for CF 
patients.
The YgD OR was significantly higher than the ORs of 
the other patterns (Table  7). However, the reliability of 
the YgD-Q (α = 0.717) was lower than that of the other 
patterns, indicating that some of the YgD-Q items might 
not have accurately reflected the YgD pattern. In other 
words, the QBYY-Q did not distinguish YgD from QD 
because YgD simultaneously included QD. The ORs sug-
gested that the QBYY-Q scores might be beneficial for 
clarifying the characteristics of deficiency syndromes in 
clinical cases.
The ORs derived from the multinomial logistic regres-
sion analysis demonstrated that each QD, BD, YnD, 
and YgD-Q score was positively associated with each 
corresponding deficiency pattern (adjusted ORs: qi 
score =  0.041, blood score =  5.877, yin score =  12.57, 
yang score  =  13.56, reference category: QD). We con-
structed an algorithm for estimating the PI of a CF 
patient, including data on age, sex, and QBYY-Q scores, 
and tested its predictability (Fig.  3). We developed and 
validated this algorithm based on the diagnostic results 
and QBYY-Q scores to predict the PIs of patients with 
CF. To evaluate the distinction possibility of the four 
deficiency patterns, we developed and validated an algo-
rithm based on diagnostic results and QBYY-Q scores. 
The algorithm was developed and validated based on 
bootstrap resampling (B  =  500) using ordinary multi-
nomial logistic regression (precision =  0.608) and sub-
scales of each deficiency pattern questionnaire, based on 
EFA (precision  =  0.530) [38]. The selected final model 
depended on the simulation results. Bootstrap valida-
tion with 500 resamples of the selected model produced 
moderate predictive performance, with Cox & Snell 
R2 = 0.346, agreement = 0.523, κ = 0.369, area under the 
curve = 0.750, precision = 0.53, and recall = 0.535. The 
prevalence and severity of ICF and CFS varied accord-
ing to ethnicity and psychosocial factors [39]. By validat-
ing the results, we confirmed the possibility of diagnosis 
using the QBYY-Q. Objective measurement of the sub-
jective severity of fatigue is difficult, but it is essential in 
implementing therapy for unexplained CF [40, 41].
The study was limited by the small number of patients 
and the single-center design. Although CFS and ICF can 
be diagnosed using international guidelines, these stand-
ards are different from PI symptoms and signs, which 
are very difficult to standardize. However, we generated 
reference data that are applicable to future studies. Thus, 
the results of the present study could be used to improve 
the care of patients with CF and CF-related disorders and 
to facilitate research on anti-CF therapies. Large clinical 
trials in multiple centers on PI and the evaluation of the 
therapeutic effects on CF in randomized clinical trials are 
needed. Additional studies are required to assess the cor-
relations between CF type and other demographic and 
clinical characteristics.
Conclusion
The QBYY-Q was a suitable instrument for estimating the 
influences of qi, blood, yin, and yang deficiencies in CF.
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